Hatem Soliman
Georgetown University(US)Moffitt Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Brain Metastases and Treatment, Immunotherapy and Immune Responses
Most-Cited Works
- → Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology(2018)1,614 cited
- → Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology(2020)1,612 cited
- → Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology(2022)945 cited
- → NCCN Guidelines Insights: Breast Cancer, Version 1.2017(2017)538 cited
- → Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology(2024)459 cited
- → NCCN Guidelines® Insights: Breast Cancer, Version 4.2023(2023)415 cited
- → TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer(2018)368 cited
- → NCCN Guidelines® Insights: Breast Cancer, Version 4.2021(2021)348 cited
- → Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology(2016)315 cited
- → Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors(2019)283 cited